His Pacing vs Biventricular Pacing for Cardiac Resynchronization Therapy: Long-Term Follow-Up From the

Emil Anton Frandsen1, Johanna Krøll1, Ulrik Winsløw1

  • 1Department of Cardiology, The Heart Centre, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.

Insights

His bundle pacing (His-CRT) and biventricular pacing (BiV-CRT) showed similar long-term performance and echocardiographic response in heart failure patients. Low implantation thresholds for His-CRT matched BiV-CRT outcomes.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • The His-Alternative I trial was the first European randomized trial comparing His bundle pacing (His-CRT) with conventional biventricular pacing (BiV-CRT) in symptomatic heart failure patients with left bundle branch block.
  • This study aimed to evaluate the long-term outcomes of these two cardiac resynchronization therapy (CRT) approaches.

Purpose of the Study:

  • To compare the long-term lead performance, survival rates, and echocardiographic response between His-CRT and BiV-CRT.
  • To assess the durability and effectiveness of His-CRT in patients with heart failure and left bundle branch block.

Main Methods:

  • 50 patients with symptomatic heart failure (HF), LVEF ≤35%, and LBBB were randomized to His-CRT or BiV-CRT.
  • Primary analyses included lead revisions, generator replacements, reinterventions, all-cause mortality or HF hospitalization, and echocardiographic response over 5 years of follow-up.

Main Results:

  • While His-CRT showed higher rates of lead revisions (37% vs 3%) and generator replacements (47% vs 10%), no significant differences in reinterventions or threshold development were found between His-CRT (with low implantation thresholds) and BiV-CRT.
  • All-cause mortality or HF hospitalization risk was similar (HR: 0.32; P = 0.147), and echocardiographic response rates were comparable (89% for His-CRT vs 90% for BiV-CRT).

Conclusions:

  • His-CRT with low implantation thresholds demonstrates comparable long-term performance and echocardiographic response to BiV-CRT in heart failure patients.
  • These findings suggest His-CRT is a viable alternative to BiV-CRT for selected patients, particularly when achieving low implantation thresholds.
Abstract

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
707
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
845
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K